Models of Pelizeaus-Merzbacher-Disease

Myelin Biology and Disorders

Volumn 2, Issue , 2004, Pages 1125-1142

  Nave, Klaus Armin ^a   Griffiths, Ian R ^b  

^a MAX PLANCK INSTITUTE OF EXPERIMENTAL MEDICINE   (Germany)

^b Institute of Comparative Medicine   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84903112806     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-012439510-7/50100-5     Document Type: Chapter

References (167)

1. Al-Saktawi K., McLaughlin M., Klugmann M., Schneider A., Barrie J.A., McCulloch M.C., Montague P., Kirkham D., Nave K.-A., Griffiths I.R. Genetic background determines phenotypic severity of the Plp rumpshaker mutation. J. Neurosci. Res. 2003, 72:12-24.
2. Anderson T.J., Montague P., Nadon N., Nave K-A., Griffiths I.R. Modification of Schwann cell phenotype with PLP transgenes: Evidence that the PLP and DM20. J. Neurosci. Res. 1997, 50:13-22.
3. Anderson T.J., Schneider A., Barrie J.A., Klugmann M., McCulloch M.C., Kirkham D., Kyriakides E., Nave K.-A., Griffiths I.R. Late-onset neurodegeneration in mice with increased dosage of the proteolipid protein gene. J. Comp. Neurol. 1998, 394:506-519.
4. Barres B.A., Hart I.K., Coles H.S., Burne J.F., Voyvodic J.T., Richardson W.D., Raff M.C. Cell death and control of cell survival in the oligodendrocyte lineage. Cell 1992, 70:31-46.
5. Barron K.D., Dentinger M.P., Csiza C.K., Keegan S.M., Mankes R. Abnormalities of central axons in a dysmyelinative rat mutant. Exp. Mol. Pathol. 1987, 47:125-142.
6. Bartlett W.P., Knapp P.E., Skoff R.P. Glial conditioned medium enables jimpy oligodendrocytes to express properties of normal oligodendrocytes: Production of myelin antigens and membranes. Glia 1998, 1:253-259.
7. Bauer J., Bradl M., Klein M., Leisser M., Deckwerth T.L., Wekerle H., Lassmann H. Endoplasmic reticulum stress in PLP-overexpressing transgenic rats: Gray matter oligodendrocytes are more vulnerable than white matter oligodendrocytes. J Neuropathol Exp Neurol. 2002, 61:12-22.
8. Baumgartner B.G., Brenig B. [The role of proteolipid proteins in the development of congenital tremors type AIII: A review], Dtsch. Tierarztl. Wochenschr. 1996, 103:404-407.
9. Beesley J.S., Lavy L., Eraydin N.B., Siman R., Grinspan J.B. Caspase-3 activation in oligodendrocytes from the myelin-deficient rat. J Neurosci Res. 2001, 64:371-379.
10. Benjamins J.A., Studzinski D.M., Skoff R.P. Analysis of myelin proteolipid protein and F0 ATPase subunit 9 in normal and jimpy CNS. Neurochem Res. 1994, 19:1013-1022.
11. Billings-Gagliardi S., Adcock L.H., Wolf M.K. Hypomyelinated mutant mice: Description of jpmsd and comparison with jp and qk on their present genetic backgrounds. Brain Res. 1980, 194:325-338.
12. Billings-Gagliardi S., Nunnari J.N., Nadon N.L., Wolf M.K. Evidence that CNS hypomyelination does not cause death of jimpy-msd mutant mice. Dev Neurosci. 1999, 21:473-482.
13. Billings-Gagliardi S., Nunnari J.J., Wolf M.K. Rumpshaker behaves like juvenile-lethal Plp mutations when combined with shiverer in double mutant mice. Dev Neurosci. 2001, 23:7-16.
14. Billings-Gagliardi S., Kirschner D.A., Nadon N.L., DiBenedetto L.M., Karthigasan J., Lane P., Pearsall G.B., Wolf M.K. Jimpy 4J: A new X-linked mouse mutation producing severe CNS hypomyelination. Dev Neurosci. 1995, 17:300-310.
15. Boison D., Stoffel W. Myelin-deficient rat: A point mutation in exon III (A→C, Thr75→Pro) of the myelin proteolipid protein causes dysmyelination and oligodendrocyte death. EMBO J. 1989, 8:3295-3302.
16. Boison D., Stoffel W. Disruption of the compacted myelin sheath of axons of the central nervous system in proteolipid protein-deficient mice. Proc. Natl. Acad. Sci. USA 1994, 91:11709-11713.
17. Boison D., Büssow H., D'Urso D., Müller H.W., Stoffel W. Adhesive properties of proteolipid protein are responsible for the compaction of CNS myelin sheaths. J. Neurosci. 1995, 15:5502-5513.
18. Bongarzone E.R., Campagnoni C.W., Kampf K., Jacobs E.C., Handley V.W., Schonmann V., Campagnoni A.T. Identification of a new exon in the myelin proteolipid protein gene encoding novel protein isoforms that are restricted to the somata of oligodendrocytes and neurons. J. Neurosci. 1999, 19:8349-8357.
19. Bongarzone E.R., Jacobs E., Schonmann V., Campagnoni A.T. Classic and soma-restricted proteolipids are targeted to different subcellular compartments in oligodendrocytes. J Neurosci. Res. 2001, 65:477-484.
20. Bongarzone E.R., Jacobs E., Schonmann V., Kampf K., Campagnoni C.W., Campagnoni A.T. Differential sensitivity in the survival of oligodendrocyte cell lines to overexpression of myelin proteolipid protein gene products. J Neurosci Res. 2001, 65:485-492.
21. Boulloche J., Aicardi J. Pelizaeus-Merzbacher disease: Clinical and nosological study. J. Child Neurol. 1986, 1:233-239.
22. Bradl M., Bauer J., Inomata T., Zielasek J., Nave K.-A., Toyka K., Lassmann H., Wekerle H. Transgenic Lewis rats overexpressing the proteolipid protein gene: Myelin degeneration and its effect on T cell-mediated experimental autoimmune encephalomyelitis. Acta Neuropathol. 1999, 97:595-606.
23. Bradl M., Linington C. Animal models of demyelination. Brain Pathol. 1996, 6:303-311.
24. Brustle O., Jones K.N., Learish R.D., Karram K., Choudhary K., Wiestler O.D., Duncan I.D., McKay R.D. Embryonic stem cell-derived glial precursors: A source of myelinating transplants. Science 1999, 285:754-756.
25. Cerghet M., Bessert D.A., Nave K.-A., Skoff R.P. Differential expression of apoptotic markers in jimpy and in PLP overexpressors: Evidence for different apoptotic pathways. J. Neurocytol. 2001, 30:841-855.
26. Cremers F.P.M., Pfeiffer R.A., van de Pol T.J.R., Hofker M.H., Kruse T.A., Wieringa B., Ropers H.H. An interstitial duplication of the X chromosome in a male allows physical fine mapping of probes from the Xq13-q22 region. Hum. Genet. 1987, 77:23-27.
27. Csiza C.K., de Lahunta A. Myelin deficiency (md): A neurologic mutant in the Wistar rat. Am J Pathol. 1979, 95:215-223.
28. Dautigny A., Mattei M.G., Morello D., Alliel P.M., Pham-Dinh D., Amar L., Arnaud D., Simon D., Mattei J.F., Guenet J.L., et al. The structural gene coding for myelin-associated proteolipid protein is mutated in jimpy mice. Nature 1986, 321:329-867.
29. Dentinger M.P., Barron K.D., Csiza C.K. Ultrastructure of the central nervous system in a myelin deficient rat. J. Neurocytol. 1982, 11:671-691.
30. Dentinger M.P., Barron K.D., Csiza C.K. Glial and axonal development in optic nerve of myelin deficient rat mutant. Brain Res. 1985, 344:255-266.
31. Dickinson P.J., Fanarraga M.L., Griffiths I.R., Barrie J.A., Kyriakides E., Montague P. Oligodendrocyte progenitors in the embryonic spinal cord express DM-20. Neuropath. Appl. Neurobiol. 1996, 22:188-198.
32. Diehl H.J., Schaich M., Budzinski R.M., Stoffel W. Individual exons encode the integral membrane domains of human myelin proteolipid protein. Proc. Natl. Acad. Sci U S A. 1986, 83:9807-9811.
33. Duncan I.D., Hammang J.P., Goda S., Quarles R.H. Myelination in the jimpy mouse in the absence of proteolipid protein. Glia 1989, 2:148-154.
34. Duncan I.D., Hammang J.P., Trapp B.D. Abnormal compact myelin in the myelin-deficient rat: Absence of proteolipid protein correlates with a defect in the intraperiod line. Proc. Natl. Acad. Sci. USA 1987, 84:6287-6291.
35. Duncan I.D., Nadon N.L., Hoffman R.L., Lunn K.F., Csiza C., Wells M.R. Oligodendrocyte survival and function in the long-lived strain of the myelin deficient rat. J Neurocytol. 1995, 24:745-762.
36. Eicher E.M., Hoppe P.C. Use of chimeras to transmit lethal genes in the mouse and to demonstrate allelism of the two X-linked male lethal genes jp and msd. J Exp. Zool. 1973, 183:181-184.
37. Ellis D., Malcom S. Proteolipid protein gene dosage effect in Pelizaeus-Merzbacher disease. Nat. Genet. 1994, 6:333-334.
38. Fanarraga M.L., Griffiths I.R., McCulloch M.C., Barrie J.A., Kennedy P.G.E., Brophy P.J. Rumpshaker: An X-linked mutation causing hypomyelination: Developmental differences in myelination and glial cells between the optic nerve and spinal cord. Glia 1992, 5:161-170.
39. Fannon A.M., Mastronardi F.G., Moscarello M.A. Isolation and identification of proteolipid proteins in jimpy mouse brain. Neurochem Res. 1994, 19:1005-1012.
40. Filbin M.T., Walsh F.S., Trapp B.D., Pizzey J.A., Tennekoon G.I. Role of myelin P0 protein as a homophilic adhesion molecule. Nature 1990, 344:871-872.
41. Garbern J.Y., Cambi F., Tang X.M., Sima A.A., Vallat J.M., Bosch E.P., Lewis R., Shy M., Sohi J., Kraft G., Chen K.L., Joshi I., Leonard D.G., Johnson W., Raskind W., Dlouhy S.R., Pratt V., Hodes M.E., Bird T., Kamholz J. Proteolipid protein is necessary in peripheral as well as central myelin. Neuron 1997, 19:205-218.
42. Garbern J., Cambi F., Shy M., Kamholz J. The molecular pathogenesis of Pelizaeus-Merzbacher disease. Arch Neurol. 1999, 56:1210-1214.
43. Garbern J.Y., Yool D.A., Moore G.J., Wilds I.B., Faulk M.W., Klugmann M., Nave K.-A., Sistermans E.A., van der Knaap M.S., Bird T.D., Shy M.E., Kamholz J.A., Griffiths I.R. Patients lacking the major CNS myelin protein, proteolipid protein 1, develop length-dependent axonal degeneration in the absence of demyelination and inflammation. Brain 2002, 125:551-561.
44. Gencic S., Hudson L. Conservative amino acid substitution in the myelin proteolipid protein of jimpymsd mice. J. Neurosci. 1990, 10:117-124.
45. Genoud S., Lappe-Siefke C., Goebbels S., Radtke F., Aguet M., Scherer S., Suter U., Nave K.-A., Mantei N. Notch-1 control of oligodendrocyte differentiation. J. Cell Biol. 2002, 158:709-718.
46. Gotow T., Leterrier J.F., Ohsawa Y., Watanabe T., Isahara K., Shibata R., Ikenaka K., Uchiyama Y. Abnormal expression of neurofilament proteins in dysmyelinating axons located in the central nervous system of jimpy mutant mice. Eur J Neurosci. 1999, 11:3893-3903.
47. Gow A., Friedrich V.L., Lazzarini R.A. Many naturally occuring mutations of myelin proteolipid protein impair its intracellular transport. J. Neurosci. Res. 1994, 37:574-583.
48. Gow A., Lazzarini R.A. A cellular mechanism governing the severity of Pelizaeus-Merzbacher disease. Nature Genetics 1996, 13:422-428.
49. Gow A., Southwood C.M., Lazzarini R.A. Disrupted proteolipid protein trafficking results in oligodendrocyte apoptosis in an animal model of Pelizaeus-Merzbacher disease. J Cell Biol. 1998, 140:925-934.
50. Griffiths I.R. Myelin mutants: Model systems to study normal and abnormal myelination. BioEssays 1996, 18:789-797.
51. Griffiths I.R., Dickinson P., Montague P. Expression of the proteolipid protein gene in glial cells of the post-natal peripheral nervous system of rodents. Neuropath. Appl. Neurobiol. 1995, 21:97-110.
52. Griffiths I.R., Klugmann M., Anderson T.J., Thomson C.E., Vouyiouklis D.A., Nave K.-A. Current concepts of PLP and its role in the nervous system. Microsc. Res. Tech. 1998, 41:344-358.
53. Griffiths I.R., Klugmann M., Anderson T., Yool D., Thomson C., Schwab M.H., Schneider A., Zimmermann F., McCulloch M., Nadon N., Nave K.-A. Axonal swellings and degeneration in mice lacking myelin proteolipid protein. Science 1998, 280:1610-1613.
54. Griffiths I.R., Schneider A., Anderson J., Nave K.-A. Transgenic and natural mouse models of proteolipid protein (PLP) related dysmyelination and demyelination. Brain Pathol. 1995, 5:275-281.
55. Griffiths I.R., Scott I., McCulloch M.C., Barrie J.A., McPhilemy K., Cattanach B.M. Rumpshaker mouse: A new X-linked mutation affecting myelination: evidence for a defect in PLP expression. J Neurocytol. 1990, 19:273-283.
56. Grinspan J.B., Coulalaglou M., Beesley J.S., Carpio D.F., Scherer S.S. Maturation-dependent apoptotic cell death of oligodendrocytes in myelin-deficient rats. J Neurosci Res. 1998, 54:623-634.
57. Gutierrez R., Boison D., Heinemann U., Stoffel W. Decompaction of CNS myelin leads to a reduction of the conduction velocity of action potentials in optic nerve. Neurosci Lett. 1996, 195:93-96.
58. Hirano A., Sax D.S., Zimmerman H.M. The fine structure of the cerebella of jimpy mice and their "normal" litter mates. J. Neuropathol. Exp. Neurol. 1969, 28:388-400.
59. Hodes M.E., Pratt V.M., Dlouhy S.R. Genetics of Pelizaeus-Merzbacher disease. Dev. Neurosci. 1994, 15:383-394.
60. Hudson L.D., Berndt J.A., Puckett C., Kozak C.A., Lazzarini R.A. Aberrant splicing of proteolipid protein mRNA in the dysmyelinating jimpy mutant mouse. Proc. Natl. Acad. Sci. USA 1987, 84:1454-1458.
61. Hudson L.D., Puckett C., Berndt J., Chan J., Gencic S. Mutation of the proteolipid protein gene (PLP) in a human X chromosome-linked disorder. Proc. Natl. Acad. Sci. USA 1989, 86:8128-8131.
62. Johnston A.W., MacKusick V.A. A sex-linked recessive form of spastic paraplegia. Am J. Hum. Genet. 1962, 14:83-94.
63. Jung M., Sommer I., Schachner M., Nave K-A. Monoclonal antibody O10 defines a conformationally sensitive cell-surface epitope of proteolipid protein (PLP): Evidence that PLP misfolding underlies dysmyelination in mutant mice. J. Neurosci. 1996, 24:7920-7929.
64. Kagawa T., Ikenaka K., Inoue Y., Kuriyama S., Tsujii T., Nakajima J., Nakao J., Aruga J., Okano H., Mikoshiba K. Glial cell degeneration and hypomyelination caused by overexpression of the myelin proteolipid protein gene. Neuron 1994, 13:427-442.
65. Karthigasan J., Evans E.L., Vouyiouklis D.A., Inouye H., Borenshteyn N., Ramamurthy G.V., Kirschner D.A. Effects of rumpshaker mutation on CNS myelin composition and structure. J Neurochem. 1996, 66:338-345.
66. Kitagawa K., Sinoway M.P., Yang C., Gould R.M., Colman D.R. A proteolipid protein gene family: Expression in sharks and rays and possible evolution from an ancestral gene encoding a pore-forming polypetide. Neuron 1993, 11:433-448.
67. Klugmann M., Schwab M., Pühlhofer A., Schneider A., Zimmermann F., Griffiths I.R., Nave K.-A. Assembly of CNS myelin in the absence of proteolipid protein. Neuron 1997, 18:59-70.
68. Knapp P.E., Bartlett W.P., Williams L.A., Yamada M., Ikenaka K., Skoff R.P. Programmed cell death without DNA fragmentation in the jimpy mouse: Secreted factors can enhance survival. Cell Death Differ. 1999, 6:136-145.
69. Knapp P.E., Ismaili S., Hauser K.F., Ghandour M.S. Abnormal Ca(2+) regulation in oligodendrocytes from the dysmyelinating jimpy mouse. Brain Res 1999, 847:332-337.
70. Knapp P.E., Maderspach K., Hauser K.F. Endogenous opioid system in developing normal and jimpy oligodendrocytes: Mu and kappa opioid receptors mediate differential mitogenic and growth responses. Glia 1998, 22:189-201.
71. Knapp P.E., Skoff R.P. A defect in the cell cycle of neuroglia in the myelin deficient jimpy mouse. Dev. Brain Res. 1987, 35:301-306.
72. Knapp P.E., Skoff R.P., Redstone D.W. Oligodendroglial cell death in jimpy mice: An explanation for the myelin deficit. J. Neurosci. 1986, 6:2813-2822.
73. Kobayashi H., Hoffman E., Marks H. The rumpshaker mutation in spastic paraplegia. Nat. Genet. 1994, 7:351-352.
74. Koeppen A.H., Ronca N.A., Greenfield E.A., Hans M.B. Defective biosynthesis of proteolipid protein in pelizaeus-Merzbacher disease. Ann. Neurol. 1987, 21:159-170.
75. Komaki H., Sasaki M., Yamamoto T., Iai M., Takashima S. Connatal Pelizaeus-Merzbacher disease associated with the jimpy(msd) mice mutation. Pediatr Neurol. 1999, 20:309-311.
76. Kraus-Ruppert R., Herschkowitz N., Fürst S. Morphological studies on neuroglial cells in the corpus callosum of the Jimpy mutant mouse. J Neuropathol Exp Neurol 1973, 32:197-202.
77. Lachapelle F., Gumpel M., Baumann N. Contribution of transplantations to the understanding of the role of the PLP gene. Neurochem. Res. 1994, 19:1083-1090.
78. Lappe-Siefke C., Goebbels S., Gravel M., Nicksch E., Lee J., Braun P.E., Griffiths I.R., Nave K.-A. Disruption of the Cnp1 gene uncouples oligodendroglial functions in axonal support and myelination. Nat. Genet. 2003, 33:366-374.
79. Laursen R.A., Samiullah M., Lees M.B. The structure of bovine brain myelin proteolipid and its organization in myelin. Proc Natl Acad Sci USA 1984, 8:2912-2916.
80. Lees M., Brostoff S.L. Proteins of myelin. Myelin 1984, 197-224. Plenum Press, New York. 2nd. ed. P. Morell (Ed.).
81. Le Goascogne C., Eychenne B., Tonon M.C., Lachapelle F., Baumann N., Robel P. Neurosteroid progesterone is up-regulated in the brain of jimpy and shiverer mice. Glia 2000, 29:14-24.
82. Lipsitz D., Goetz B.D., Duncan I.D. Apoptotic glial cell death and kinetics in the spinal cord of the myelin-deficient rat. J. Neurosci. Res. 1998, 51:497-507.
83. Macklin W.B., Gardinier M.V., King K.D., Kampf K. An AG-GG transition at a splice site in the myelin proteolipid protein gene in jimpy mice results in the removal of an exon. FEBS Lett. 1987, 223:417-421.
84. Mastronardi F.G., Ackerley C.A., Arsenault L., Roots B.I., Moscarello M.A. Demyelination in a transgenic mouse: A model for multiple sclerosis. J Neurosci Res. 1993, 36:315-324.
85. Mattei M.G., Alliel P.M., Dautigny A., Passage E., Pham-Dinh D., Mattei J.F., Jolles P. The gene encoding for the major brain proteolipid (PLP) maps on the q-22 band of the human X chromosome. Hum. Genet. 1986, 72:352-353.
86. McLaughlin M., Hunter D.J.B., Thomson C.E., Yool D., Kirkham D., Freer A.A., Griffiths I.R. Evidence for possible interactions between PLP and DM20 within the myelin sheath. Glia 2002, 39:31-36.
87. Meier C., Bischoff A. Dysmyelination in "jimpy" mouse. Electron microscopic study. J. Neuropathol. Exp. Neurol. 1974, 33:343-353.
88. Meier C., Bischoff A. Oligodendroglial cell development in jimpy mice and controls. An electron-microscopic study in the optic nerve. J Neurol. Sci. 1975, 26:517-528.
89. Meier C., Herschkowitz N., Bischoff A. Morphological and biochemical observations in the Jimpy spinal cord. Acta Neuropathol (Berl) 1974, 27:349-362.
90. Meier H., MacPike A.D. A neurological mutation (msd) of the mouse causing a deficiency of myelin synthesis. Exp Brain Res. 1970, 10:512-525.
91. Merzbacher L. Eine eigenartige familiäre Erkrankungsform (Aplasia axialis extracorticolis congenita). Z. Ges. Neurol. Psychiatr. 1910, 3:1-138.
92. Miller M.J., Haxhiu M.A., Georgiadis P., Gudz T.I., Kangas C.D., Macklin W.B. Proteolipid protein gene mutation induces altered ventilatory response to hypoxia in the myelin-deficient rat. J Neurosci. 2003, 23:2265-2273.
93. Milner R.J., Lai C., Nave K.-A., Lenoir D., Ogata J., Sutcliffe J.G. Nucleotide sequences of two mRNAs for rat brain myelin proteolipid protein. Cell 1985, 42:931-939.
94. Mimault C., Giraud G., Courtois V., Cailloux F., Boire J.Y., Dastugue B., Boespflug-Tanguy O. Proteolipoprotein gene analysis in 82 patients with sporadic Pelizaeus-Merzbacher Disease: Duplications, the major cause of the disease, originate more frequently in male germ cells, but point mutations do not. The Clinical European Network on Brain Dysmyelinating Disease. Am. J. Hum Genet. 1999, 65:360-369.
95. Morello D., Dautigny A., Pham-Dinh D., Jolles P. Myelin proteolipid protein (PLP and DM-20) transcripts are deleted in jimpy mutant mice. EMBO J. 1986, 5:3489-3493.
96. Nadon N.L., Arnheiter H., Hudson L.D. A combination of PLP and DM20 transgenes promotes partial myelination in the jimpy mouse. J. Neurochem. 1994, 63:822-833.
97. Nadon N.L., Duncan I.D., Hudson L.D. A point mutation in the proteolipid protein gene of the 'shaking pup' interrupts oligodendrocyte development. Development 1990, 110:529-537.
98. Nadon N.L., West M. Myelin proteolipid protein: Function in myelin structure is distinct from its role in oligodendrocyte development. Dev Neurosci. 1998, 20:533-539.
99. Naidu S., Dlouhy S.R., Geraghty M.T., Hodes M.E. A male child with the rumpshaker mutation, X-linked spastic paraplegia/Pelizaeus-Merzbacher disease and lysinuria. J Inherit Metab Dis. 1997, 20:811-816.
100. Nave K.-A. Neurological mouse mutants and genes of myelin. J. Neurosci. Res. 1994, 38:607-612.
101. Nave K.-A., Lai C., Bloom F.E., Milner R.J. Jimpy mutant mouse: A 74-base deletion in the mRNA for myelin proteolipid protein and evidence for a primary defect in RNA splicing. Proc. Natl. Acad. Sci. USA 1986, 83:9264-9268.
102. Nave K.-A., Lai C., Bloom F.E., Milner R.J. Splice site selection in the proteolipid protein (PLP) gene transcript and primary structure of the DM-20 protein of central nervous system myelin. Proc. Natl. Acad. Sci. USA 1987, 84:5665-5669.
103. Nave K.-A., Boespflug-Tanguy O. Developmental defects of myelin formation: From X-linked mutations to human dysmyelinating diseases. The Neuroscientist 1996, 2:33-43.
104. Nave K.-A., Lai C., Bloom F.E., Milner R.J. Splice site selection in the proteolipid protein (PLP) gene transcript and primary structure of the DM-20 protein of central nervous system myelin. Proc. Natl. Acad. Sci. USA 1987, 84:5665-5669.
105. Nave K.-A., Milner R.J. Proteolipid proteins: Structure and genetic expression in normal and myelin-deficient mutant mice. Crit. Rev. Neurobiol. 1989, 5:65-91.
106. Pearsall G.B., Nadon N.L., Wolf M.K., Billings-Gagliardi S. Jimpy-4J mouse has a missense mutation in exon 2 of the Plp gene. Dev Neurosci. 1997, 19:337-341.
107. Pelizaeus F. Über eine eigenthümliche Form spastischer Lähmung mit Cerebral erscheinungen auf hereditärer Grundlage (Multiple Sklerose). Arch. Psychiatr. 1885, 16:698-710.
108. Phillips R.J. Jimpy, a new totally sex-linked gene in the house mouse. Z. Induk. Abstamm. Vererbunsl. 1954, 86:322.
109. Popot J.L., Pham-Dinh D., Dautigny A. Major myelin proteolipid: The 4-a-helix topology. J. Membrane Biol. 1991, 120:233-246.
110. Pringle N.P., Nadon N.L., Rhode D.M., Richardson W.D., Duncan I.D. Normal temporal and spatial distribution of oligodendrocyte progenitors in the myelin-deficient (md) rat. J Neurosci Res. 1997, 47:264-270.
111. Pucket C., Hudson L., Ono K., Friedrich V., Benecke J., Dubois-Dalcq M., Lazzarini R.A. Myelin specific proteolipid protein is expressed in myelinating Schwann cells but not incorporated into myelin sheaths. J. Neurosci. Res. 1987, 18:511-518.
112. Raskind W.H., Williams C.A., Hudson L.D., Bird T.D. Complete deletion of the proteolipid protein gene (PLP) in a family with X-linked Pelizaeus-Merzbacher disease. Am. J. Med. Genet. 1991, 49:1355-1360.
113. Readhead C., Schneider A., Griffiths I., Nave K.-A. Premature arrest of myelin formation in transgenic mice with increased proteolipoprotein gene dosage. Neuron 1994, 12:583-595.
114. Ron D. Translational control in the endoplasmic reticulum stress response. J Clin. Invest. 2002, 110:1383-1388.
115. Rosenbluth J., Stoffel W., Schiff R. Myelin structure in proteolipid protein (PLP)-null mouse spinal cord. J. Comp. Neurol. 1996, 371:336-344.
116. Saugier-Veber P., Munnich A., Bonneau D., Rozet J.M., Le Merrer M., Gil R., Boespflug-Tanguy O. X-linked spastic paraplegia and Pelizaeus-Merzbacher disease are allelic disorders at the proteolipid protein locus. Nat. Genet. 1994, 6:257-261.
117. Scherer S.S. Molecular genetics of demyelination: New wrinkles on an old membrane. Neuron 1997, 18:13-16.
118. Schneider A., Griffiths I.R., Readhead C., Nave K.-A. Dominant-negative action of the jimpy mutation in mice complemented with an autosomal transgene for myelin proteolipid protein. Proc. Natl. Acad. Sci. USA 1995, 92:4447-4451.
119. Schneider A., Montague P., Griffiths I., Fanarraga M., Kennedy P., Brophy P., Nave K.-A. Uncoupling of hypomyelination and glial cell death by a mutation in the proteolipid protein gene. Nature 1992, 358:758-761.
120. Seeman P., Paderova K., Benes V., Sistermans E.A. A severe connatal form of Pelizaeus Merzbacher disease in a Czech boy caused by a novel mutation (725C>A, Ala242Glu) at the 'jimpy(msd) codon' in the PLP gene. Int. J. Mol. Med. 2002, 9:125-129.
121. Seitelberger F. Pelizaeus-Merzbacher disease. Handbook of Clinical Neurology 1970, Vol 10:150-202. North Holland, New York. P.J. Vinken, G.W. Bruyn (Eds.).
122. Seitelberger F., Urbanitz I., Nave K.-A. Pelizaeus-Merzbacher Disease. Handbook of Clinical Neurology 1996, Vol. 22:559-579. (Ch. 26), Elsevier Science B. V., Amsterdam. P.J. Vinken, G.W. Bruyn (Eds.).
123. Sherman M.Y., Goldberg A.L. Cellular defenses against unfolded proteins: A cell biologist thinks about neurodegenerative diseases. Neuron 2001, 29:15-32.
124. Shy M.E., Hobson G., Jain M., Boespflug-Tanguy O., Garbern J., Sperle K., Li W., Gow A., Rodriguez D., Bertini E., Mancias P., Krajewski K., Lewis R., Kamholz J. Schwann cell expression of PLP1 but not DM20 is necessary to prevent neuropathy. Ann Neurol. 2003, 53:354-365.
125. Sidman R.L., Dickie M.M., Appel S.H. Mutant mice (quaking and jimpy) with deficient myelination in the central nervous system. Science 1964, 144:309-311.
126. Simons M., Krämer E.M., Macchi P., Rathke-Hartlieb S., Trotter J., Nave K.-A., Schulz J.B. Overexpression of the myelin proteolipid protein leads to accumulation of cholesterol and proteolipid protein in endosomes/lysosomes: Implications for Pelizaeus-Merzbacher disease. J Cell Biol. 2002, 157:327-336.
127. Simons M., Krämer E.M., Thiele C., Stoffel W., Trotter J. Assembly of myelin by association of proteolipid protein with cholesterol- and galactosylceramide-rich membrane domains. J Cell Biol. 2000, 151:143-154.
128. Simons-Johnson R., Roder J.C., Riordan J.R. Over-expression of the DM-20 myelin proteolipid causes central nervous system demyelination in transgenic mice. J. Neurochem. 1995, 64:967-976.
129. Sistermans E.A., de Coo R.F., De Wijs I.J., Van Oost B.A. Duplication of the proteolipid protein gene is the major cause of Pelizaeus-Merzbacher disease. Neurology 1998, 50:1749-1754.
130. Sistermans E.A., de Wijs I.J., de Coo R.F., Smit L.M., Menko F.H., van Oost B.A. A (G-to-A) mutation in the initiation codon of the proteolipid protein gene causing a relatively mild form of Pelizaeus-Merzbacher disease in a Dutch family. Hum Genet. 1996, 97:337-339.
131. Skoff R.P. Myelin deficit in the Jimpy mouse may be due to cellular abnormalities in astroglia. Nature 1976, 264:560-562.
132. Skoff R.P. Increased proliferation of oligodendrocytes in the hypomyelinated mouse mutant-jimpy. Brain Res. 1982, 248:19-31.
133. Skoff R.P. Programmed cell death in the dysmyelinating mutants. Brain Pathol. 1995, 5:283-288.
134. Snipes G.J., Suter U., Shooter E. The genetics of myelin. Curr. Op. Neurobiol. 1993, 3:694-702.
135. Southwood C., Gow A. Molecular pathways of oligodendrocyte apoptosis revealed by mutations in the proteolipid protein gene. Microsc Res Tech. 2001, 52:700-708.
136. Southwood C.M., Garbern J., Jiang W., Gow A. The unfolded protein response modulates disease severity in Pelizaeus-Merzbacher disease. Neuron 2002, 36:585-596.
137. Spassky N., Goujet-Zalc C., Parmantier E., Olivier C., Martinez S., Ivanova A., Ikenaka K., Macklin W., Cerruti I., Zalc B., Thomas J.L. Multiple restricted origin of oligodendrocytes. J. Neurosci. 1998, 18:8331-8343.
138. Sporkel O., Uschkureit T., Bussow H., Stoffel W. Oligodendrocytes expressing exclusively the DM20 isoform of the proteolipid protein gene: Myelination and development. Glia 2002, 37:19-30.
139. Stecca B., Southwood C.M., Gragerov A., Kelley K.A., Friedrich V.L., Gow A. The evolution of lipophilin genes from invertebrates to tetrapods: DM-20 cannot replace proteolipid protein in CNS myelin. J Neurosci. 2000, 20:4002-4010.
140. Stoffel W., Hillen H., Giersiefen H. Structure and molecular arrangement of proteolipid protein of central nervous system myelin. Proc. Natl. Acad. Sci. U S A. 1984, 81:5012-5016.
141. Thomson C.E., Anderson T.J., McCulloch M.C., Dickinson P.J., Vouyiouklis D.A., Griffiths I.R. The early phenotype associated with the jimpy mutation of the proteolipid protein gene. J. Neurocytol. 1999, 28:207-221.
142. Tosic M., Dolivo M., Domanska-Janik K., Matthieu J.M. Paralytic tremor (pt): A new allele of the proteolipid protein gene in rabbits. J Neurochem. 1994, 63:2210-2216.
143. Trapp B.D., Nishiyama A., Cheng D., Macklin W. Differentiation and death of premyelinating oligodendrocytes in developing rodent brain. J Cell Biol. 1997, 137:459-468.
144. Uschkureit T., Sporkel O., Bussow H., Stoffel W. Rumpshaker-like proteolipid protein (PLP) ratio in a mouse model with unperturbed structural and functional integrity of the myelin sheath and axons in the central nervous system. Glia 2001, 35:63-71.
145. Utzschneider D., Black J.A., Kocsis J.D. Conduction properties of spinal cord axons in the myelin-deficient rat mutant. Neuroscience 1992, 49:221-228.
146. Vela J.M., Dalmau I., Gonzalez B., Castellano B. The microglial reaction in spinal cords of jimpy mice is related to apoptotic oligodendrocytes. Brain Res. 1996, 712:134-142.
147. Vela J.M., Gonzalez B., Castellano B. Understanding glial abnormalities associated with myelin deficiency in the jimpy mutant mouse. Brain Res. Rev. 1998, 26:29-42.
148. Vermeesch M.K., Knapp P.E., Skoff R.P., Studzinski D.M., Benjamins J.A. Death of individual oligodendrocytes in jimpy brain precedes expression of proteolipid protein. Dev. Neurosci. 1990, 12:303-315.
149. Wahle S., Stoffel W. Cotranslational integration of myelin proteolipid protein (PLP) into the membrane of endoplasmic reticulum: Analysis of topology by glycosylation scanning and protease domain protection assay. Glia 1998, 24:226-235.
150. Weimbs T., Stoffel W. Proteolipid protein (PLP) of CNS myelin: Positions of free, disulfide-bonded, and fatty acid thioester-linked cysteine residues and implications for the membrane topology of PLP. Biochemistry 1992, 31:12289-12296.
151. Weimbs T., Stoffel W. Topology of CNS myelin proteolipid protein: Evidence for the nonenzymatic glycosylation of extracytoplasmic domains in normal and diabetic animals. Biochemistry 1994, 33:10408-10415.
152. Werner H., Dimou L., Klugmann M., Pfeiffer S., Nave K.-A. Multiple splice isoforms of proteolipid M6B in neurons and oligodendrocytes. Mol. Cell. Neurosci. 2001, 18:593-605.
153. Werner H., Jung M., Klugmann M., Sereda M., Griffiths I., Nave K.-A. Mouse models of myelin diseases. Brain Pathol. 1998, 8:771-793.
154. Willard H.F., Riordan J.R. Assignment of the gene for myelin proteolipid protein to the X chromosome: Implications for X-linked myelin disorders. Science 1985, 230:940-942.
155. Williams W.C., Gard A.L. In vitro death of jimpy oligodendrocytes: Correlation with onset of DM-20/PLP expression and resistance to oligodendrogliotrophic factors. J Neurosci Res. 1997, 50:177-189.
156. Wolf M.K., Holden A.B. Tissue culture analysis of the inherited defect of central nervous system myelination in jimpy mice. J Neuropathol Exp Neurol. 1969, 28:195-213.
157. Wolf M.K., Nunnari J.N., Billings-Gagliardi S. Quaking*shiverer double-mutant mice survive for at least 100 days with no CNS myelin. Dev Neurosci. 1999, 21:483-490.
158. Woodward K., Malcolm S. Proteolipid protein gene: Pelizaeus-Merzbacher disease in humans and neurodegeneration in mice. Trends Genet. 1999, 15:125-128.
159. Woodward K., Malcolm S. CNS myelination and PLP gene dosage. Pharmacogenomics 2001, 2:263-272.
160. Wu Q., Miller R.H., Ransohoff R.M., Robinson S., Bu J., Nishiyama A. Elevated levels of the chemokine GRO-1 correlate with elevated oligodendrocyte progenitor proliferation in the jimpy mutant. J Neurosci. 2000, 20:2609-2617.
161. Yamamura T., Konola J.T., Wekerle H., Lees M.B. Monoclonal antibodies against myelin proteolipid protein: Identification and characterization of two major determinants. J Neurochem. 1991, 57:1671-1680.
162. Yan Y., Lagenaur C., Narayanan V. Molecular cloning of M6: Identification of a PLP/DM-20 gene family. Neuron 1993, 11:423-431.
163. Yool D.A., Edgar J.M., Montague P., Malcolm S. The proteolipid protein gene and myelin disorders in man and animal models. Hum. Mol. Genet. 2000, 9:987-992.
164. Yool D.A., Klugmann M., McLaughlin M., Vouyiouklis D.A., Dimou L., Barrie J.A., McCulloch M.C., Nave K.-A., Griffiths I.R. Myelin proteolipid proteins promote the interaction of oligodendrocytes and axons. J. Neurosci. Res. 2001, 63:151-164.
165. Yool D., Klugmann M., Barrie J.A., McCulloch M.C., Nave K.-A., Griffiths I.R. Observations on the structure of myelin lacking the major proteolipid protein. Neuropath. Appl. Neurobiol. 2002, 28:75-78.
166. Young W., Rosenbluth J., Wojak J.C., Sakatani K. Extracellular potassium activity and axonal conduction in spinal cord of the myelin-deficient mutant rat. Exp. Neurol. 1989, 106:41-51.
167. Yu W.P., Collarini E.J., Pringle N.P., Richardson W.D. Embryonic expression of myelin genes: Evidence for a focal source of oligodendrocyte precursors in the ventricular zone of the neural tube. Neuron 1994, 12:1353-1362.